immun
mucos
surfac
becom
attract
rout
vaccin
deliveri
abil
induc
mucos
immun
although
variou
method
induc
mucos
immun
develop
laboratori
focus
develop
adenovirus
replicationcompet
replic
incompet
vector
present
report
summar
progress
sequenc
entir
bovin
genom
identifi
region
delet
subsequ
use
insert
site
foreign
gene
develop
recombin
viral
vaccin
use
recombin
virus
demonstr
proofofprincipl
develop
mucos
immun
importantli
induc
protect
bovin
herp
viru
natur
host
cattl
final
demonstr
immun
protect
occur
even
anim
preexist
antibodi
vector
vaccin
continu
one
import
diseas
manag
tool
control
infecti
diseas
livestock
human
inde
increas
resist
bacteria
antibiot
continu
pauciti
antivir
drug
mani
virus
vaccin
attract
approach
infecti
diseas
control
although
vaccin
practis
year
mani
licens
vaccin
use
today
recent
advanc
molecular
biolog
immunolog
combin
understand
pathogenesi
mani
infecti
agent
stimul
renew
interest
develop
safer
efficaci
vaccin
evid
increas
number
articl
directli
focus
vaccin
genesi
new
journal
dedic
specif
vaccinolog
activ
focus
improv
convent
vaccin
deliveri
meet
need
today
manag
system
well
develop
total
new
approach
vaccin
present
novel
vaccin
technolog
use
develop
subunit
vaccin
chimer
vaccin
peptid
vaccin
genedelet
vaccin
vector
vaccin
dna
vaccin
plantbas
vaccin
novel
approach
requir
much
detail
character
genet
organ
pathogen
gene
respons
virul
induct
immun
result
increas
knowledg
abil
manipul
genom
pathogen
unpreced
posit
develop
better
live
vector
vaccin
safer
also
abl
induc
wide
rang
protect
immun
respons
rang
humor
cellular
immun
well
system
mucos
immun
gener
mucos
immun
especi
import
hope
prevent
infect
although
rare
vaccin
induc
steril
immun
mucos
immun
limit
replic
pathogen
site
entri
mucos
immun
reduc
rate
infect
rate
replic
either
prevent
attach
pathogen
host
cell
interf
transcript
proper
assembl
pathogen
intracellularli
enhanc
antigen
uptak
clearanc
pathogen
well
improv
present
antigen
immun
system
increas
immun
respons
present
number
strategi
employ
enhanc
mucos
immun
includ
mucos
adjuv
cholera
toxin
isaka
et
al
microparticl
especi
oral
deliveri
microparticl
gener
biodegrad
even
use
pulsatil
releas
polylactid
glycolid
algin
particl
shown
effect
especi
oral
deliveri
mcdermott
et
al
bowersock
et
al
dna
vaccin
cox
et
al
donnelli
et
al
yokonama
et
al
lewi
et
al
transgen
plant
arakawa
et
al
live
vector
pastoret
et
al
yilma
et
al
live
vector
attract
engin
way
induc
immun
vector
engin
correctli
induc
immun
array
protein
encod
gene
insert
vector
inde
one
first
licens
recombin
vaccin
employ
vaccinolog
includ
vaccinia
viru
carri
gene
encod
rabi
viru
glycoprotein
vaccin
present
licens
immun
wildlif
rabi
vaccin
reduc
spread
rabi
viru
wildlif
popul
also
reduc
spillov
viru
infect
wildlif
domest
anim
human
pastoret
et
al
brochier
pastoret
mackowiak
et
al
sinc
initi
licens
vacciniarabi
glycoprotein
recombin
numer
live
viral
bacteri
vector
investig
potenti
vaccin
vector
kit
et
al
cirillo
et
al
sheppard
present
review
summar
progress
made
use
adenovirus
potenti
vector
induct
immun
anim
adenovirus
first
isol
earli
sinc
differ
serotyp
isol
human
mammalian
avian
speci
ishibashi
yasu
sinc
varieti
differ
adenovirus
surpris
induc
varieti
differ
diseas
specif
host
howev
one
gener
pathogen
enter
via
mucos
surfac
therefor
replic
least
initi
mucos
site
respiratori
gastrointestin
tract
reason
adenovirus
attract
vector
deliv
vaccin
mucos
surfac
import
featur
adenovirus
vector
certain
serotyp
often
associ
mild
clinic
diseas
molecular
biolog
replic
strategi
adenovirus
well
character
replic
extrem
high
titr
pfu
ml
therebi
reduc
cost
vaccin
product
deliveri
recent
clone
entir
genom
bacteri
plasmid
provid
rapid
construct
isol
recombin
chartier
et
al
final
number
effect
adenoviru
vaccin
alreadi
licens
use
anim
human
therebi
provid
experi
adenoviru
vaccin
regard
safeti
efficaci
factor
critic
success
develop
live
vector
vaccin
adenovirus
linear
doublestrand
dna
genom
vari
size
kb
depend
speci
viru
isol
genom
packag
nake
icosahedr
capsid
sinc
nake
virus
gener
stabl
environ
envelop
virus
anoth
attract
featur
regard
use
adenovirus
vector
vaccin
sinc
icosahedr
capsid
rigid
amount
dna
packag
insid
capsid
strictli
control
space
limit
case
human
adenovirus
demonstr
genom
size
effect
packag
ghoshchoudhuri
et
al
sinc
addit
genom
provid
much
space
insert
new
gene
recombin
adenoviru
vaccin
develop
replac
exist
viral
sequenc
gene
interest
depend
specif
sequenc
replac
recombin
virus
either
replic
compet
replicationdefect
recent
studi
also
begun
develop
helperdepend
gutless
adenovirus
contain
littl
adenoviru
sequenc
help
increas
clone
capac
vector
thu
allow
insert
larg
foreign
dna
addit
potenti
remov
adenoviru
gene
sequenc
whose
express
may
harm
effect
desir
applic
recombin
vector
sinc
helper
viru
use
propag
desir
gutless
vector
one
main
problem
associ
product
vector
final
separ
helper
vector
virus
purif
howev
constant
improvementsmodif
product
gutless
vector
help
obtain
purifi
vector
contain
helper
viru
park
et
al
adenovirus
use
success
vector
import
fulli
character
genom
order
identifi
specif
region
viru
delet
manipul
requir
thorough
understand
replic
strategi
viru
specif
gene
involv
replic
step
adenoviru
genom
replic
gener
divid
two
distinct
chronolog
event
earli
event
occur
prior
replic
viral
genom
control
earli
region
e
contrast
late
event
occur
viral
genom
replic
begin
primarili
concern
product
viral
structur
protein
turn
late
region
gene
l
earli
region
consist
four
differ
region
distribut
throughout
genom
earli
region
contain
differ
transcript
regulatori
gene
region
polypeptid
first
express
follow
infect
cell
viru
import
regul
transcript
viral
cellular
gene
sinc
gene
product
region
critic
initi
viru
replic
delet
gene
result
replicationdefect
viru
howev
still
possibl
use
virus
delet
region
vector
provid
gene
product
complement
cell
line
gene
product
must
express
suffici
level
complement
defect
viru
although
viru
produc
cell
line
introduc
anim
produc
gene
product
viru
infect
result
abort
infect
graham
prevec
grunhau
horwitz
replicationdefect
virus
still
express
insert
gene
interest
induc
immun
respons
anim
sinc
replicationdefect
consid
safe
littl
chanc
environment
spread
sinc
replicationdefect
virus
builtin
suicid
mechan
biolog
control
spread
vector
make
attract
regulatori
agenc
environmentalist
although
delet
viru
may
pick
region
transfect
cell
produc
replic
compet
virus
chanc
occur
remot
sinc
use
human
adenoviru
rather
bovin
adenoviru
transfect
cell
region
often
use
insert
foreign
gene
region
region
requir
viru
replic
vitro
therefor
replac
region
foreign
gene
result
replicationdefect
viru
even
though
region
essenti
viru
replic
vitro
conserv
adenovirus
studi
todat
suggest
viru
retain
region
purpos
studi
primarili
human
serotyp
shown
differ
protein
produc
region
involv
bind
mhc
class
molecul
modul
lysi
tumor
necrosi
factor
downregul
epiderm
growth
factor
receptor
host
cell
paabo
et
al
good
et
al
krajcsi
et
al
result
delet
region
may
modul
pathogenesi
virus
morin
et
al
ginsberg
et
al
studi
bovin
adenovirus
show
evid
increas
lymphocyt
infiltr
pathogenesi
increas
pathogenesi
seen
human
adenoviru
mutant
may
univers
mittal
et
al
howev
mutant
adenoviru
commerci
import
investig
impact
virus
viral
pathogenesi
region
anoth
region
shown
use
insert
site
foreign
gene
four
gene
product
involv
transit
viru
earlytol
gene
express
shutoff
host
cell
gene
express
viru
replic
assembl
human
adenovirus
region
essenti
virus
replic
cell
express
gene
product
whether
essenti
adenovirus
yet
determin
one
would
assum
therefor
virus
cell
line
express
need
develop
one
establish
recombin
viru
one
expect
develop
viru
one
requir
cell
line
express
gene
product
suffici
level
complement
genedelet
virus
level
gene
would
toxic
cell
thu
addit
manipul
viru
critic
develop
appropri
cell
line
express
virus
although
preliminari
proofofprincipl
base
use
human
adenovirus
vector
studi
immun
respons
rodent
recent
progress
analysi
genom
anim
virus
provid
much
broader
experi
use
virus
vector
variou
anim
speci
includ
bovin
adenovirus
porcin
adenovirus
ovin
adenovirus
fowl
adenovirus
canin
adenovirus
mittal
et
al
klonjkowski
et
al
xu
et
al
sheppard
et
al
reddi
et
al
experi
anim
adenovirus
clearli
demonstr
common
adenovirus
studi
todat
also
demonstr
signific
differ
thu
one
directli
translat
experi
one
adenoviru
anoth
exampl
genom
organ
adenovirus
similar
ident
even
similar
genom
organ
transfect
effici
human
anim
adenovirus
may
vari
one
two
order
magnitud
low
transfect
effici
hamper
develop
anim
adenovirus
vector
unfortun
reason
differ
present
well
known
fortun
novel
approach
use
homolog
recombin
system
e
coli
allow
us
overcom
impedi
low
transfect
effici
anim
adenovirus
rapidli
reconstruct
recombin
express
number
differ
viral
protein
chartier
et
al
laboratori
focus
primarili
bovin
porcin
adenovirus
vector
mittal
et
al
zakhartchouk
et
al
reddi
et
al
howev
possibl
develop
virus
vector
requir
complet
sequenc
respect
genom
character
variou
region
viral
genom
could
use
insert
foreign
gene
secondli
requir
product
cell
line
isol
recombin
achiev
two
goal
need
complet
entir
transcript
map
sequenc
genom
reddi
et
al
genbank
access
fig
analysi
genom
similar
adenovirus
focus
character
region
specif
order
identifi
boundari
region
eventu
remov
enhanc
code
capac
viru
insert
foreign
gene
combin
code
capac
three
region
bovin
kb
kb
kb
kb
follow
remov
three
region
possibl
insert
singl
larg
gene
essenti
promot
etc
kb
combin
gene
total
kb
sinc
adenovirus
thought
abl
packag
genom
possibl
insert
addit
kb
total
kb
foreign
gene
could
theoret
insert
three
differ
locat
could
combin
singl
locat
present
insert
gene
three
region
yet
introduc
gene
three
differ
region
construct
howev
possibl
present
investig
studi
incorpor
gene
encod
cytokin
combin
gene
isol
pathogen
attempt
enhanc
immun
respons
mucos
surfac
addit
provid
addit
capac
gene
insert
delet
specif
gene
delet
gene
also
alter
replic
capac
virus
therebi
make
potenti
safer
vector
delet
believ
result
product
replic
incompet
virus
therefor
viral
recombin
isol
viral
function
need
provid
tran
complement
cell
line
although
extra
step
product
recombin
virus
result
safer
vaccin
sinc
recombin
infect
anim
undergo
abort
infect
therefor
spread
environ
consid
import
regulatori
agenc
whose
concern
environment
releas
potenti
recombin
sinc
viru
undergo
singl
cycl
replic
step
level
antigen
express
vivo
believ
lower
recombin
replic
host
exampl
gene
insert
region
infect
normal
host
cell
undergo
number
replic
cycl
vivo
addit
replic
believ
increas
quantiti
protein
produc
vivo
recogn
host
immun
respons
result
replicationcompet
virus
may
induc
higher
level
immun
replicationincompet
virus
test
feasibl
use
bovin
adenoviru
live
vector
induct
system
mucos
immun
use
bovin
herp
gd
model
gene
insert
adenovirus
chose
gene
previous
shown
glycoprotein
could
induc
protect
immun
cattl
regardless
whether
purifi
virusinfect
cell
babiuk
et
al
produc
recombin
fig
schemat
represent
bovin
genom
adapt
reddi
et
al
locat
major
region
genom
highlight
main
viral
protein
e
region
code
earli
protein
wherea
l
region
code
late
protein
fig
immun
gd
follow
immun
adenoviru
vector
express
gd
anim
vaccin
either
intranas
intraderm
twice
interv
total
week
last
immun
serum
antibodi
antibodysecret
cell
lung
assay
elisa
elispot
respect
host
cell
membran
parallel
also
insert
truncat
form
gd
tgd
lack
transmembran
anchor
would
allow
secret
gd
extracellular
environ
regardless
whether
gd
tgd
use
recombin
produc
signific
level
immun
laboratori
anim
cotton
rat
cattl
mittal
et
al
zakhartchouk
et
al
deliveri
recombin
via
system
administr
induc
excel
level
system
immun
mucos
immun
contrast
deliveri
recombin
via
intranas
rout
lead
high
mucos
lung
antibodi
level
iga
igg
well
system
immun
demonstr
nasal
lung
antibodi
actual
synthes
site
immun
elispot
assay
perform
case
anim
immun
intranas
rout
show
evid
antibodi
secret
cell
mucosa
wherea
system
immun
anim
fig
data
support
previou
studi
lead
concept
compartment
immun
system
common
mucos
immun
system
one
major
concern
viral
vector
vaccin
fear
preexist
antibodi
vector
reduc
immun
respons
transgen
level
nonprotect
dong
et
al
schulick
et
al
papp
et
al
although
immun
anim
antibodi
adenovirus
produc
slightli
higher
immun
respons
transgen
fig
clearli
demonstr
cattl
possess
high
level
antibodi
adenovirus
time
vaccin
still
develop
signific
immun
respons
transgen
thu
anim
seroneg
transgen
time
immun
rapidli
develop
specif
immun
transgen
even
singl
immun
immun
respons
boost
secondari
immun
two
week
boost
calv
challeng
intranas
challeng
plaqueform
unit
per
anim
anim
clinic
evalu
independ
temperatur
depress
sever
nasal
lesion
etc
fig
demonstr
signific
differ
clinic
score
anim
immun
fig
immun
respons
gd
follow
immun
bovin
seroposit
anim
gd
recombin
administ
intranas
day
day
serum
antibodi
respons
gd
dark
bar
measur
neutral
elisa
lightshad
bar
dna
technolog
van
drunen
littelvan
den
hurk
et
al
dna
vaccin
cox
et
al
inde
gd
consid
major
target
neutral
antibodi
glycoprotein
essenti
viru
entri
cell
test
potenti
vector
insert
entir
gd
gene
would
function
authent
viralproduc
protein
anchor
gd
recombin
compar
equival
lack
gd
gene
although
anim
shed
viru
first
day
anim
vaccin
group
rapidli
elimin
viru
day
littl
viru
shed
nasal
passag
contrast
anim
immun
still
shed
signific
level
viru
rapid
clearanc
viru
associ
rapid
increas
iga
antibodi
nasal
passag
adenoviru
recombin
also
made
express
gd
gene
region
bovin
although
level
immun
anim
immun
recombin
slightli
lower
replicationcompet
recombin
level
immun
induc
recombin
suffici
limit
viru
replic
reduc
clinic
sign
determin
broad
util
use
adenovirus
vector
test
number
gene
differ
virus
efficaci
express
adenoviru
especi
interest
gene
rna
virus
sinc
rna
viru
gene
rare
transcrib
nucleu
other
experienc
difficulti
express
gene
rna
virus
recombin
normal
replic
nucleu
test
whether
adenovirus
could
also
express
gene
rna
viru
todat
express
gene
bovin
bovin
viru
diarrhea
corona
virus
enhanc
level
express
bovin
coronaviru
gene
use
synthet
intron
possibl
modifi
splice
gene
transport
nucleu
cytoplasm
reddi
et
al
use
synthet
intron
abl
increas
gene
express
thu
feel
system
applic
express
gene
major
pathogen
interest
level
express
certain
gene
may
also
increas
resynthesi
gene
improv
codon
bias
alter
secondari
structur
mrna
taylor
et
al
human
adenovirus
use
extens
develop
recombin
virus
test
variou
anim
model
system
rosenth
et
al
howev
sinc
human
adenovirus
gener
restrict
host
rang
therefor
infect
replic
well
nonhuman
speci
appear
appropri
use
adenovirus
isol
speci
interest
vector
type
studi
done
abl
get
true
appreci
potenti
benefit
use
adenoviru
vector
differ
speci
studi
bovin
adenoviru
clearli
demonstr
proofofprincipl
vector
use
cattl
even
import
observ
seroposit
cattl
immun
vector
possibl
reason
mucos
immun
level
often
sustain
long
serum
antibodi
level
therebi
allow
infect
mucos
cell
upper
respiratori
tract
even
presenc
high
serum
antibodi
level
viru
enter
mucos
cell
produc
suffici
level
antigen
induc
immun
respons
host
preliminari
result
suggest
intranas
administr
effect
intratrach
administr
recombin
adenovirus
seroposit
anim
studi
support
content
virus
attach
nasal
mucosa
neutral
antibodi
intratrach
administr
probabl
lead
neutral
viru
viru
initi
infect
support
content
come
fact
serum
antibodi
transud
occur
effici
lower
lung
nasal
mucosa
support
deliveri
adenoviru
vector
nasal
passag
come
studi
demonstr
deliveri
antigen
nasopharyng
lymph
node
tissu
one
effici
method
stimul
immun
respons
studi
indic
rout
administr
need
import
consider
compar
immun
data
adenoviru
vector
develop
effect
protocol
deliveri
rapidli
expand
knowledg
host
respons
antigen
role
cytokin
polar
modul
respons
predict
play
import
role
improv
potenti
adenoviru
vector
exampl
possibl
construct
adenoviru
vector
coexpress
antigen
cytokin
interest
express
cytokin
induc
mucos
immun
enhanc
efficaci
recombin
importantli
induc
desir
type
immun
respons
base
recent
progress
use
adenovirus
vaccin
vector
infecti
diseas
cancer
immunotherapi
confid
recombin
adenovirus
becom
import
part
armamentarium
vaccin
human
anim
